CVS HEALTH Corp (CVS) · Insider trading
What CVS HEALTH's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$323.71M
2 insiders, 0% under a plan
Net, 12 months
−$323.71M
bought less sold
Latest filing
2026-06-29
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Robbins LarryDirector | – | $571.19M | 13 | 2026-05-21 | – |
| Mandadi TilakEVP, Chief Exp & Tech Officer | – | $6.23M | 1 | 2026-05-08 | 10,133 |
| Mahoney Michael FDirector | $2.00M | – | 1 | 2025-02-18 | 39,356 |
| Finucane Anne A.Director | – | $532,650 | 1 | 2025-08-20 | – |
| Clark James DavidSVP, Cont & Chief Acct Officer | – | $498,488 | 1 | 2025-03-05 | 8,394 |
| Sansone Guy PDirector | $100,009 | – | 1 | 2025-06-05 | 12,007 |
| Capozzi Heidi BEVP and Chief People Officer | $1,990 | – | 1 | 2024-10-23 | – |
| Nelson Steven HEVP and President, Aetna | $1,289 | – | 1 | 2025-01-23 | – |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Robbins LarryDirector | Saleindirect | 370,462 | 93.45 | $34.62M | 4,824,799 | Form 4 |
| 2026-05-20 | Robbins LarryDirector | Saleindirect | 797,628 | 93.48 | $74.56M | 5,415,633 | Form 4 |
| 2026-05-20 | Robbins LarryDirector | Saleindirect | 152,691 | 94.81 | $14.48M | 5,262,942 | Form 4 |
| 2026-05-20 | Robbins LarryDirector | Saleindirect | 66,881 | 95.67 | $6.40M | 5,196,061 | Form 4 |
| 2026-05-20 | Robbins LarryDirector | Saleindirect | 800 | 96.28 | $77,024 | 5,195,261 | Form 4 |
| 2026-05-19 | Robbins LarryDirector | Saleindirect | 1,983,387 | 94.45 | $187.33M | 6,213,412 | Form 4 |
| 2026-05-19 | Robbins LarryDirector | Saleindirect | 151 | 95.18 | $14,372 | 6,213,261 | Form 4 |
| 2026-05-08 | Mandadi TilakEVP, Chief Exp & Tech Officer | Sale | 69,551 | 89.58 | $6.23M | 10,133 | Form 4 |
| 2025-08-20 | Finucane Anne A.Director | Saleindirect | 7,500 | 71.02 | $532,650 | 22,156 | Form 4 |
| 2025-06-05 | Sansone Guy PDirector | Buy | 1,570 | 63.70 | $100,009 | 12,007 | Form 4 |
| 2025-05-06 | Robbins LarryDirector | Saleindirect | 150,000 | 66.67 | $10.00M | 8,196,799 | Form 4 |
| 2025-05-05 | Robbins LarryDirector | Saleindirect | 1,226,933 | 67.37 | $82.66M | 8,443,798 | Form 4 |
| 2025-05-05 | Robbins LarryDirector | Saleindirect | 96,999 | 67.99 | $6.59M | 8,346,799 | Form 4 |
| 2025-05-02 | Robbins LarryDirector | Saleindirect | 1,679,736 | 67.39 | $113.20M | 10,267,063 | Form 4 |
| 2025-05-02 | Robbins LarryDirector | Saleindirect | 222,556 | 68.38 | $15.22M | 10,044,507 | Form 4 |
| 2025-05-02 | Robbins LarryDirector | Saleindirect | 373,776 | 69.66 | $26.04M | 9,670,731 | Form 4 |
| 2025-03-05 | Clark James DavidSVP, Cont & Chief Acct Officer | Sale | 7,513 | 66.35 | $498,488 | 8,394 | Form 4 |
| 2025-02-18 | Mahoney Michael FDirector | Buy | 30,000 | 66.70 | $2.00M | 39,356 | Form 4 |
| 2025-01-23 | Nelson Steven HEVP and President, Aetna | Buyindirect | 24 | 53.70 | $1,289 | 24 | Form 4 |
| 2024-10-23 | Capozzi Heidi BEVP and Chief People Officer | Buyindirect | 35 | 56.85 | $1,990 | 85 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
57 × grant or award29 × shares withheld for tax2 × returned to the company2 × option exercise1 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | Clark James DavidSVP, Cont & Chief Acct Officer | Shares withheld for tax F | −454 | 90.98 | 27,606 | Form 4 |
| 2026-05-31 | Compton-Phillips AmyEVP, Chief Medical Officer | Shares withheld for tax F | −7,618 | 90.98 | 9,557 | Form 4 |
| 2026-05-31 | Newman BrianEVP, Chief Financial Officer | Shares withheld for tax F | −2,478 | 90.98 | 3,008 | Form 4 |
| 2026-05-21 | Aguirre FernandoDirector | Returned to the company D | −1,563 | 93.50 | 10,513 | Form 4 |
| 2026-05-20 | Aguirre FernandoDirector | Returned to the company D | −30,437 | 93.78 | 12,076 | Form 4 |
| 2026-05-14 | Brown C David IIDirector | Grant or award A | +1,544 | 97.15 | 129,316 | Form 4 |
| 2026-05-14 | Sansone Guy PDirector | Grant or award A | +1,447 | 97.15 | 15,106 | Form 4 |
| 2026-05-14 | Norwalk Leslie VDirector | Grant or award A | +1,447 | 97.15 | 7,376 | Form 4 |
| 2026-05-14 | Kirby J ScottDirector | Grant or award A | +1,447 | 97.15 | 14,434 | Form 4 |
| 2026-05-14 | Balser Jeffrey R.Director | Grant or award A | +2,058 | 97.15 | 15,717 | Form 4 |
| 2026-05-14 | Aguirre FernandoDirector | Grant or award A | +1,563 | 97.15 | 42,513 | Form 4 |
| 2026-04-01 | Capozzi Heidi BEVP and Chief People Officer | Shares withheld for tax F | −1,334 | 72.49 | 13,023 | Form 4 |
| 2026-04-01 | Clark James DavidSVP, Cont & Chief Acct Officer | Shares withheld for tax F | −3,262 | 72.49 | 15,457 | Form 4 |
| 2026-04-01 | Joyner J. DavidDirector, President, CEO and Chair | Shares withheld for tax F | −8,029 | 72.49 | 70,349 | Form 4 |
| 2026-04-01 | Khichi Samrat S.EVP, CPO and General Counsel | Shares withheld for tax F | −3,541 | 72.49 | 33,421 | Form 4 |
| 2026-04-01 | Mandadi TilakEVP, Chief Exp & Tech Officer | Shares withheld for tax F | −3,634 | 72.49 | 79,684 | Form 4 |
| 2026-04-01 | Nelson Steven HEVP and President, Aetna | Shares withheld for tax F | −2,432 | 72.49 | 2,900 | Form 4 |
| 2026-04-01 | Shah Prem SEVP and Group President | Shares withheld for tax F | −1,484 | 72.49 | 64,356 | Form 4 |
| 2026-03-31 | Capozzi Heidi BEVP and Chief People Officer | Grant or award A | +10,025 | 71.82 | 84,450 | Form 4 |
| 2026-03-31 | Clark James DavidSVP, Cont & Chief Acct Officer | Grant or award A | +11,138 | 71.82 | 35,539 | Form 4 |
| 2026-03-31 | Compton-Phillips AmyEVP, Chief Medical Officer | Grant or award A | +5,569 | 71.82 | 58,660 | Form 4 |
| 2026-03-31 | Joyner J. DavidDirector, President, CEO and Chair | Grant or award A | +86,326 | 71.82 | 160,860 | Form 4 |
| 2026-03-31 | Khichi Samrat S.EVP, CPO and General Counsel | Grant or award A | +12,531 | 71.82 | 38,139 | Form 4 |
| 2026-03-31 | Mandadi TilakEVP, Chief Exp & Tech Officer | Grant or award A | +22,277 | 71.82 | 88,543 | Form 4 |
| 2026-03-31 | Nelson Steven HEVP and President, Aetna | Grant or award A | +22,277 | 71.82 | 43,606 | Form 4 |
| 2026-03-31 | Newman BrianEVP, Chief Financial Officer | Grant or award A | +19,493 | 71.82 | 41,354 | Form 4 |
| 2026-03-31 | Shah Prem SEVP and Group President | Grant or award A | +25,062 | 71.82 | 62,852 | Form 4 |
| 2026-03-19 | Gallina John EDirector | Grant or award A | +582 | 71.86 | 582 | Form 4 |
| 2026-02-28 | Joyner J. DavidDirector, President and CEO | Shares withheld for tax F | −1,944 | 79.90 | 49,996 | Form 4 |
| 2026-02-28 | Khichi Samrat S.EVP, CPO and General Counsel | Shares withheld for tax F | −7,886 | 79.60 | 29,775 | Form 4 |
| 2026-01-01 | Shah Prem SEVP and Group President | Shares withheld for tax F | −247 | 80.13 | 61,509 | Form 4 |
| 2025-12-01 | Clark James DavidSVP, Cont & Chief Acct Officer | Shares withheld for tax F | −220 | 79.10 | 24,401 | Form 4 |
| 2025-11-30 | Capozzi Heidi BEVP and Chief People Officer | Shares withheld for tax F | −9,470 | 80.36 | 11,415 | Form 4 |
| 2025-11-30 | Farah Roger NDirector | Shares withheld for tax F | −9,748 | 80.36 | 19,438 | Form 4 |
| 2025-11-30 | Mandadi TilakEVP, Chief Exp & Tech Officer | Shares withheld for tax F | −6,575 | 80.36 | 74,085 | Form 4 |
| 2025-11-20 | Aguirre FernandoDirector | Grant or award A | +1,800 | 76.04 | 40,950 | Form 4 |
| 2025-11-20 | Balser Jeffrey R.Director | Grant or award A | +1,775 | 76.04 | 13,659 | Form 4 |
| 2025-11-20 | Brown C David IIDirector | Grant or award A | +1,775 | 76.04 | 127,772 | Form 4 |
| 2025-11-20 | Finucane Anne A.Director | Grant or award A | +591 | 76.04 | 591 | Form 4 |
| 2025-11-20 | Kirby J ScottDirector | Grant or award A | +1,652 | 76.04 | 12,987 | Form 4 |
| 2025-11-20 | Norwalk Leslie VDirector | Grant or award A | +1,652 | 76.04 | 5,929 | Form 4 |
| 2025-11-20 | Sansone Guy PDirector | Grant or award A | +1,652 | 76.04 | 13,659 | Form 4 |
| 2025-11-20 | Shulman Douglas H.Director | Grant or award A | +1,652 | 76.04 | 5,929 | Form 4 |
| 2025-08-31 | Mandadi TilakEVP, Chief Exp & Tech Officer | Shares withheld for tax F | −12,834 | 73.15 | 63,952 | Form 4 |
| 2025-08-31 | Shah Prem SEVP and Group President | Shares withheld for tax F | −6,995 | 73.15 | 60,632 | Form 4 |
| 2025-05-31 | Compton-Phillips AmyEVP, Chief Medical Officer | Grant or award A | +46,845 | 64.04 | 46,845 | Form 4 |
| 2025-05-31 | Compton-Phillips AmyEVP, Chief Medical Officer | Grant or award A | +6,246 | 64.04 | 53,091 | Form 4 |
| 2025-05-31 | Newman BrianEVP, Chief Financial Officer | Grant or award A | +21,861 | 64.04 | 21,861 | Form 4 |
| 2025-05-15 | Aguirre FernandoDirector | Grant or award A | +2,263 | 60.47 | 39,150 | Form 4 |
| 2025-05-15 | Balser Jeffrey R.Director | Grant or award A | +2,232 | 60.47 | 11,884 | Form 4 |
| 2025-05-15 | Brown C David IIDirector | Grant or award A | +2,232 | 60.47 | 125,997 | Form 4 |
| 2025-05-15 | Finucane Anne A.Director | Grant or award A | +692 | 60.47 | 692 | Form 4 |
| 2025-05-15 | Kirby J ScottDirector | Grant or award A | +2,769 | 60.47 | 11,335 | Form 4 |
| 2025-05-15 | Mahoney Michael FDirector | Grant or award A | +144 | 60.47 | 6,345 | Form 4 |
| 2025-05-15 | Norwalk Leslie VDirector | Grant or award A | +2,077 | 60.47 | 4,277 | Form 4 |
| 2025-05-15 | Sansone Guy PDirector | Grant or award A | +2,077 | 60.47 | 10,437 | Form 4 |
| 2025-05-15 | Shulman Douglas H.Director | Grant or award A | +2,077 | 60.47 | 4,277 | Form 4 |
| 2025-04-01 | Joyner J. DavidDirector, President and CEO | Grant or award A | +53,324 | – | 82,515 | Form 4/A |
| 2025-04-01 | Capozzi Heidi BEVP and Chief People Officer | Grant or award A | +11,768 | 67.98 | 95,310 | Form 4 |
| 2025-04-01 | Clark James DavidSVP, Cont & Chief Acct Officer | Shares withheld for tax F | −2,266 | 67.98 | 11,240 | Form 4 |
| 2025-04-01 | Clark James DavidSVP, Cont & Chief Acct Officer | Grant or award A | +14,710 | 67.98 | 24,707 | Form 4 |
| 2025-04-01 | Cowhey Thomas F.EVP and CFO | Shares withheld for tax F | −3,203 | 67.98 | 50,188 | Form 4 |
| 2025-04-01 | Cowhey Thomas F.EVP and CFO | Grant or award A | +16,181 | 67.98 | 41,109 | Form 4 |
| 2025-04-01 | Joyner J. DavidDirector, President and CEO | Shares withheld for tax F | −1,847 | 67.98 | 51,940 | Form 4 |
| 2025-04-01 | Khichi Samrat S.EVP, CPO and General Counsel | Shares withheld for tax F | −1,548 | 67.98 | 21,700 | Form 4 |
| 2025-04-01 | Khichi Samrat S.EVP, CPO and General Counsel | Grant or award A | +16,181 | 67.98 | 41,569 | Form 4 |
| 2025-04-01 | Mandadi TilakEVP, Chief Experience & Tech | Shares withheld for tax F | −995 | 67.98 | 43,503 | Form 4 |
| 2025-04-01 | Mandadi TilakEVP, Chief Experience & Tech | Grant or award A | +20,594 | 67.98 | 116,257 | Form 4 |
| 2025-04-01 | Nelson Steven HEVP and President, Aetna | Grant or award A | +21,329 | 67.98 | 21,329 | Form 4 |
| 2025-04-01 | Shah Prem SEVP and Group President | Shares withheld for tax F | −1,308 | 67.98 | 47,251 | Form 4 |
| 2025-04-01 | Shah Prem SEVP and Group President | Grant or award A | +26,478 | 67.98 | 58,166 | Form 4 |
| 2025-03-17 | Shah Prem SEVP and Group President | Option exercise M | +846 | 62.21 | 43,190 | Form 4 |
| 2025-03-05 | Clark James DavidSVP, Cont & Chief Acct Officer | Option exercise M | +7,513 | 62.21 | 15,907 | Form 4 |
| 2025-02-28 | Cowhey Thomas F.EVP and CFO | Shares withheld for tax F | −5,318 | 65.72 | 45,256 | Form 4 |
| 2025-02-28 | Joyner J. DavidDirector, President and CEO | Shares withheld for tax F | −1,944 | 65.72 | 46,717 | Form 4 |
| 2025-02-28 | Khichi Samrat S.EVP, CPO and General Counsel | Shares withheld for tax F | −5,604 | 65.72 | 20,106 | Form 4 |
| 2024-12-05 | Finucane Anne A.Director | Gift G | −2,665 | 56.86 | 4,567 | Form 4 |
| 2024-11-30 | Mandadi TilakEVP, Chief DDAT Officer | Grant or award A | +50,125 | 59.85 | 99,747 | Form 4 |
| 2024-11-30 | Capozzi Heidi BEVP and Chief People Officer | Grant or award A | +83,542 | 59.85 | 83,542 | Form 4 |
| 2024-11-30 | Farah Roger NDirector | Grant or award A | +50,125 | 59.85 | 50,125 | Form 4 |
| 2024-11-30 | Clark James DavidSVP, Cont & Chief Acct Officer | Shares withheld for tax F | −86 | 59.85 | 8,394 | Form 4 |
| 2024-11-21 | Aguirre FernandoDirector | Grant or award A | +2,364 | 57.10 | 36,887 | Form 4 |
| 2024-11-21 | Balser Jeffrey R.Director | Grant or award A | +2,375 | 57.10 | 9,652 | Form 4 |
| 2024-11-21 | Brown C David IIDirector | Grant or award A | +2,331 | 57.10 | 123,765 | Form 4 |
| 2024-11-21 | Deparle Nancy AnnDirector | Grant or award A | +2,331 | 57.10 | 34,169 | Form 4 |
| 2024-11-21 | Kirby J ScottDirector | Grant or award A | +2,933 | 57.10 | 8,566 | Form 4 |
| 2024-11-21 | Mahoney Michael FDirector | Grant or award A | +2,200 | 57.10 | 6,201 | Form 4 |
| 2024-11-21 | Millon Jean PierreDirector | Grant or award A | +2,200 | 57.10 | 4,514 | Form 4 |
| 2024-11-21 | Norwalk Leslie VDirector | Grant or award A | +2,200 | 57.10 | 2,200 | Form 4 |
| 2024-11-21 | Sansone Guy PDirector | Grant or award A | +2,200 | 57.10 | 8,360 | Form 4 |
| 2024-11-21 | Shulman Douglas H.Director | Grant or award A | +2,200 | 57.10 | 2,200 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.